REVENUE (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2020 USD ($) segment	Jun. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Number of reportable segments | segment			2
Revenue, net	$ 45,712	$ 28,146	$ 76,366	$ 57,657
Contract receivables, current	1,200		1,200		$ 1,100
Contract receivables, noncurrent	3,900		3,900		3,700
Current portion of deferred revenue, and other	8,600		8,600		$ 8,700
Contract liabilities, revenue recognized			2,000
Contract liabilities, increase due to additional deferred sales			1,300
Scil Animal Care Company
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Contract with customer, liability	600		600
North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	28,982	26,396	56,631	54,888
International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	16,730	1,750	19,735	2,769
POC Lab Instruments & Other | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	1,942	1,404	3,314	3,307
POC Lab Instruments & Other | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	1,928	16	2,117	16
Sales-type leases | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	1,020	1,492	2,264	3,234
Sales-type leases | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	278	0	323	0
POC Lab Consumables | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	13,537	13,182	27,223	25,499
POC Lab Consumables | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	9,470	25	10,032	25
POC Imaging | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	4,148	4,166	7,644	9,231
POC Imaging | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	4,404	1,064	5,762	1,408
PVD | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	4,880	2,721	9,384	5,392
PVD | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	650	645	1,501	1,320
OVP | North America
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	3,455	3,431	6,802	8,225
OVP | International
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, net	$ 0	$ 0	$ 0	$ 0